Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-25 @ 5:19 AM
NCT ID:
NCT00002427
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are HIV-positive.
* Have a viral load of 5,000 to 100,000 copies/ml.
* Are willing to stop all anti-HIV medications for at least 28 days before receiving study drugs.
* Are at least 18 years old.
Exclusion Criteria
Patients will not be eligible for this study if they:
* Have a history of opportunistic (AIDS-related) infection.
* Have a history of pancreatitis or other serious condition.
* Have any cancer that will require chemotherapy within the next 24 weeks.
* Are allergic to ddI or d4T.
* Have received an HIV vaccine within 28 days of study entry.
* Have received a red blood cell transfusion within the past 60 days, or have had repeated transfusions at any time in the past.
* Abuse alcohol or drugs.
* Have received certain medications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00002427
Study Brief:
Protocol Section:
NCT00002427